Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1966 1
1967 5
1968 4
1969 4
1970 2
1971 1
1972 1
1973 2
1974 5
1975 2
1979 1
1981 4
1982 3
1983 1
1985 4
1986 1
1987 3
1988 2
1989 3
1990 3
1991 3
1992 2
1993 8
1994 5
1995 4
1996 9
1997 2
1998 6
1999 3
2000 4
2001 1
2002 2
2003 4
2004 12
2005 10
2006 15
2007 24
2008 22
2009 13
2010 27
2011 22
2012 26
2013 29
2014 19
2015 34
2016 27
2017 23
2018 19
2019 20
2020 30
2021 27
2022 29
2023 41
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Results by year

Filters applied: . Clear all
Page 1
Application of moisturizer to neonates prevents development of atopic dermatitis.
Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, Shigematsu Y, Yoshida K, Niizeki H, Motomura K, Sago H, Takimoto T, Inoue E, Kamemura N, Kido H, Hisatsune J, Sugai M, Murota H, Katayama I, Sasaki T, Amagai M, Morita H, Matsuda A, Matsumoto K, Saito H, Ohya Y. Horimukai K, et al. Among authors: inoue e. J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6. doi: 10.1016/j.jaci.2014.07.060. J Allergy Clin Immunol. 2014. PMID: 25282564 Free article. Clinical Trial.
Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial.
Natsume O, Kabashima S, Nakazato J, Yamamoto-Hanada K, Narita M, Kondo M, Saito M, Kishino A, Takimoto T, Inoue E, Tang J, Kido H, Wong GW, Matsumoto K, Saito H, Ohya Y; PETIT Study Team. Natsume O, et al. Among authors: inoue e. Lancet. 2017 Jan 21;389(10066):276-286. doi: 10.1016/S0140-6736(16)31418-0. Epub 2016 Dec 9. Lancet. 2017. PMID: 27939035 Clinical Trial.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. Among authors: inoue e. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
Reply: To PMID 25282564.
Horimukai K, Morita K, Inoue E, Saito H, Ohya Y. Horimukai K, et al. Among authors: inoue e. J Allergy Clin Immunol. 2015 Apr;135(4):1088-1089. doi: 10.1016/j.jaci.2014.12.1934. Epub 2015 Feb 7. J Allergy Clin Immunol. 2015. PMID: 25665730 No abstract available.
An Anatomical Dissection Method for Observation of Fibrous Facial Structures.
Hashiguchi SI, Hayakawa K, Inoue E, Han A, Iwanaga J, Tabira Y, Yamashita A, Rikimaru H, Kiyokawa K, Watanabe K. Hashiguchi SI, et al. Among authors: inoue e. Plast Reconstr Surg. 2023 Mar 1;151(3):569-579. doi: 10.1097/PRS.0000000000009975. Epub 2022 Nov 22. Plast Reconstr Surg. 2023. PMID: 36821571
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
Kawakami H, Sunakawa Y, Inoue E, Matoba R, Noda K, Sato T, Suminaka C, Yamaki M, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Yabusaki H, Matsuyama J, Takahashi M, Makiyama A, Hayashi H, Chamoto K, Honjo T, Nakagawa K, Ichikawa W, Fujii M. Kawakami H, et al. Among authors: inoue e. Eur J Cancer. 2023 May;184:10-20. doi: 10.1016/j.ejca.2023.02.003. Epub 2023 Feb 10. Eur J Cancer. 2023. PMID: 36889037
495 results